The Trump administration has issued a new government-wide policy halting federally funded dangerous gain-of-function (DGOF) research in the U.S. and abroad. The policy, which fulfills a Trump executive order, establishes stronger oversight for high-risk life sciences research and restricts funding to institutions with inadequate biosafety standards, while preserving critical biomedical work under new safeguards.
Aug 10, 2026 · 8 sources
Aug 10, 2026 · 2 sources
Aug 10, 2026 · 3 sources
Aug 10, 2026 · 8 sources
Story comments
Loading comments…